Cipla Global

Rediff.com » News » Cipla Global

News for Cipla Global

News
Business

'14+ Anti-Obesity Drugs In The Pipeline'

The semaglutide patent expiry next year could unleash a wave of generic versions from Indian drugmakers, with prices expected to go lower -- at least 80 per cent. IMAGE: Pens for the diabetes drug......

Cipla ready to partner in Covid vaccine distribution

However, Cipla was very clear it does not want to get into vaccine manufacturing. Sohini Das reports. IMAGE: Healthcare workers wearing PPE kits carry syringes towards a Covid-19......

Cipla to price Remdesivir for Covid-19 under Rs 5,000

Hetero has priced the injectable drug at Rs 5,400 per 100 mg vial. With more drugmakers in line to launch the drug soon, the prices may see a further erosion. Sohini Das reports. IMAGE: An......

Recharge Zones To Cool Clothing: Indian Companies' Summer Strategies

Several firms are stepping up to help their workforce cope with soaring temperatures. IMAGE: Workers drink water as they take a break at a construction site on a hot summer day in New Delhi, May......

Why Is USFDA Inspecting India Pharma Firms?

Kindly note the image has been posted only for representational purposes.Photograph: Kind courtesy Pixabay.com The Indian pharmaceutical industry's recent tryst with the US drug regulator......

Cipla Q2 profit up 3.7% at Rs 1,353 cr

Pharma major Cipla Ltd on Thursday reported a 3.7 per cent rise in consolidated net profit at Rs 1,353.37 crore for the second quarter ended September 30, 2025. Photograph: Danish Siddiqui/Reuters......

Weightloss Drugs Hit 1,000 Crore Mark

'As more patients are prescribed these drugs, intolerance due to gastrointestinal and other side effects will become more visible, leading to higher discontinuation rates.' IMAGE: A pharmacist......

Factors that will guide the markets this week

In an event-heavy week, stock investors will track ongoing quarterly earnings, the US Federal Reserve's interest rate decision, and macroeconomic data for market direction, analysts said.......

USFDA's new draft biosimilar rules to benefit Indian biotech cos

The US Food and Drug Administration’s (USFDA)’s new draft guidelines aimed at speeding up and reducing the cost of developing biosimilars — lower-priced, near-replicas of complex biologic......

Messiah of the masses: Cipla's global crusade for low cost drugs

In 1935, when Khwaja Abdul Hamied set up Cipla in Central Mumbai to manufacture medicines in India, few could have predicted that in the next few decades the company would take on the world's......

Cipla Global

News for Cipla Global

'14+ Anti-Obesity Drugs In The Pipeline'

Cipla ready to partner in Covid vaccine distribution

Cipla to price Remdesivir for Covid-19 under Rs 5,000

Recharge Zones To Cool Clothing: Indian Companies' Summer Strategies

Why Is USFDA Inspecting India Pharma Firms?

Cipla Q2 profit up 3.7% at Rs 1,353 cr

Weightloss Drugs Hit 1,000 Crore Mark

Factors that will guide the markets this week

USFDA's new draft biosimilar rules to benefit Indian biotech cos

Messiah of the masses: Cipla's global crusade for low cost drugs

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS